XORTX Therapeutics, Inc. (XRTX)
0.9702
-0.04
(-3.94%)
USD |
NASDAQ |
Oct 20, 16:00
1.05
+0.08
(+8.23%)
After-Hours: 20:00
XORTX Therapeutics Price : 0.9702 for Oct. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.22 | 1.24 | 0.9901 | 1.01 | 130103.0 |
| Oct 16, 2026 | 1.39 | 1.416 | 1.21 | 1.24 | 95826.00 |
| Oct 15, 2026 | 1.53 | 1.54 | 1.41 | 1.42 | 127192.0 |
| Oct 14, 2026 | 1.60 | 1.71 | 1.56 | 1.56 | 79480.00 |
| Oct 13, 2026 | 1.62 | 1.73 | 1.51 | 1.68 | 177604.0 |
| Oct 12, 2026 | 1.40 | 1.90 | 1.39 | 1.72 | 1.761M |
| Oct 09, 2026 | 2.05 | 2.080 | 1.36 | 1.41 | 18.65M |
| Oct 08, 2026 | 1.75 | 1.90 | 1.72 | 1.85 | 10.68M |
| Oct 07, 2026 | 1.73 | 1.75 | 1.69 | 1.745 | 21733.00 |
| Oct 06, 2026 | 1.75 | 1.788 | 1.71 | 1.73 | 40942.00 |
| Oct 05, 2026 | 1.73 | 1.73 | 1.69 | 1.70 | 8938.00 |
| Oct 02, 2026 | 1.717 | 1.795 | 1.70 | 1.714 | 4475.00 |
| Oct 01, 2026 | 1.69 | 1.75 | 1.69 | 1.73 | 22084.00 |
| Sep 30, 2026 | 1.70 | 1.72 | 1.69 | 1.69 | 26084.00 |
| Sep 29, 2026 | 1.70 | 1.74 | 1.69 | 1.70 | 71431.00 |
| Sep 28, 2026 | 1.69 | 1.741 | 1.69 | 1.71 | 30006.00 |
| Sep 25, 2026 | 1.74 | 1.82 | 1.69 | 1.69 | 46861.00 |
| Sep 24, 2026 | 1.69 | 1.78 | 1.69 | 1.72 | 51336.00 |
| Sep 23, 2026 | 1.80 | 1.830 | 1.69 | 1.70 | 59419.00 |
| Sep 22, 2026 | 1.91 | 1.93 | 1.78 | 1.86 | 79640.00 |
| Sep 21, 2026 | 1.99 | 2.09 | 1.85 | 1.95 | 227454.0 |
| Sep 18, 2026 | 1.95 | 2.65 | 1.74 | 1.92 | 7.220M |
| Sep 17, 2026 | 1.75 | 1.78 | 1.590 | 1.66 | 2.237M |
| Sep 16, 2026 | 1.85 | 1.85 | 1.765 | 1.78 | 49605.00 |
| Sep 15, 2026 | 2.05 | 2.07 | 1.81 | 1.88 | 95125.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 2.645 |
| InMed Pharmaceuticals, Inc. | 1.34 |
| Target Group, Inc. (Canada) | 0.0007 |
| NervGen Pharma Corp. | 1.545 |
| Milestone Pharmaceuticals, Inc. | 0.7133 |
Price Related Metrics
| PEG Ratio | -0.0078 |
| Price to Book Value | 0.3050 |
| Earnings Yield | -282.9% |
| Market Cap | 1.679M |
| PEGY Ratio | -0.0078 |